DelSiTech, the leading biodegradable silica -based drug delivery technology company, is hosting a webinar on long-acting injectables on the 12th September, 2024, at 3 PM London / 10 AM New York time. The webinar is an excellent opportunity to learn about the landscape, benefits, and technologies of long-acting injectables from the top scientists in the field.
Dr. René Holm, a professor in pharmaceutical physical chemistry at the University of Southern Denmark, will lead us through the long-acting injectables landscape enabling more effective treatment. Dr. Peter Markland, a pharmaceutical scientist from Tolmar with over 20 years of experience in drug delivery will discuss the benefits of long-acting injectables in treating various diseases. Dr. Mika Jokinen, CSO at DelSiTech and a principal lecturer in chemical and biochemical engineering with over 20 years of R&D experience in silica-based biomaterial will present the Silica Matrix technology used by DelSiTech.
This 90-minute live webinar is free to attend. See you at the webinar!